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ABSTRACT
Objectives: To determine the short-term effects of adjuvant or primary curative radiotherapy (RT) on the urinary system 
in women with gynecologic cancer.
Material and methods: This is a prospective, concurrent cohort study including 55 patients with gynecologic cancer 
who were divided into three groups. Group 1 included 10 patients who were administered adjuvant RT following a radical 
hysterectomy (RH); Group 2 included 36 patients who were administered adjuvant RT following a type 1 hysterectomy and 
Group 3 included 9 patients who were administered primary curative RT. Urogynecologic assessments were carried out on 
patients before and six months after the treatment.
Results: Compared to pretreatment, no significant differences were observed in any of the three groups after treatment 
in terms of incontinence, first urge to urinate, normal urge to urinate, severe urge to urinate and changes in residual urine 
volumes. There was a significant decrease in maximal vesical pressure after treatment in Group 1 and Group 3. The maxi-
mum detrusor pressure decreased significantly in Group 1. The post-treatment decline in bladder capacity in Group 1 and 
Group 2 was also significant.
Conclusions: RH and pelvic RT cause lower urinary system dysfunction. Especially patients who receive primary curative 
RT and patients who are administered RT after RH, where more pelvic denervation occurs, are at higher risk due to high 
doses of RT.
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INTRODUCTION
Lower urinary system dysfunctions are frequently ob-
served in benign and malignant gynecologic diseases due 
to close anatomical, embryological and functional relation-
ships of the urinary and genital system. Symptoms emerge 
due to invasion or involvement of the urinary system, com-
pression of the mass, or treatment of a pathologic condition 
[1]. Although urinary dysfunctions may develop secondary 
to malignancy, they frequently occur due to surgery and/or 
radiation therapy (RT) for the treatment of gynecologic can-
cer [2–4]. Urinary incontinence (UI) is the most important 
lower urinary system dysfunction caused by gynecologic 
cancer treatments. Other long-term morbidities include 
genitourinary fistula, ureteral stenosis, and hemorrhagic 
cystitis [5]. Symptoms originating from the lower urinary 
system bring out serious hygiene and social problems, and 
may result in the development of psychological symptoms 
such as insecurity, shame, guilt, and denial in the affected 
women [6]. They may also cause avoidance of social activi-
ties, isolation, and sexual function disorders, consequently 
leading to decreased quality of life (QoL) [7]. 
Nowadays, it seems crucial to keep QoL unaffected while 
increasing the lifespan as a result of advanced gynecologic 
cancer treatments. Data regarding pre- and post-treatment 
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urodynamic evaluation of gynecologic cancer treatment 
methods and lower urinary system dysfunctions are limited. 
The aim of our study was to identify short-term (six months) 
effects of adjuvant or primary curative RT on the urinary 
system in women with gynecologic cancer, and to compare 
these with the results of urodynamic investigations before 
and after treatment. 
MATERIAL AND METHODS
Fifty-five patients with endometrial cancer (n = 36), 
early-stage cervical cancer (n = 10), and local advanced cer-
vical cancer (n = 9), who underwent adjuvant or primary RT 
at the Gynecologic Oncology Clinic of Tepecik Training and 
Research Hospital between 2011 and 2012, were included. 
Local Ethics Committee approved of the study and written 
informed consent was obtained.
Our study population was subdivided into three groups: 
10 early-stage cervical cancer patients who received ad-
juvant RT due to lymphovascular space invasion (LVSI) in 
their type III radical hysterectomy (RH) specimen (group 1); 
36 endometrial cancer patients who received adjuvant RT 
after total abdominal hysterectomy and bilateral salpin-
go-oophorectomy (TAH + BSO), pelvic + para-aortic lymph 
node dissection and omentectomy (group 2); 9 patients with 
stage IIB or advanced stage cervical cancer who received 
directly primary curative RT (group 3). Patients who received 
systemic chemotherapy during curative RT were listed sepa-
rately. Total pelvic dose of external radiotherapy (ERT), and 
total reference dose of intracavitary brachytherapy were 
recorded for each individual. Acute side effects of radiation 
which occurred either during RT procedure or within six 
months after radiation were considered. Urogynecologic 
assessment was performed twice: before treatment and six 
months after the treatment.
Detailed obstetric, gynecologic, and urologic history 
was obtained from all patients. The presence of UI was 
checked with different stress tests such as Valsalva and 
cough tests, which were performed at maximal bladder 
capacity. Subjects with UI were considered as “stress test” 
positive. Then, patients were asked to empty the bladder 
and post-voiding residue (PVR) volume was measured 
by inserting a sterile catheter through the urethral me-
atus. Uterus- or ovary-based pathologies were evaluated 
by transvaginal ultrasound and recorded. The ultrasound 
examination was repeated for post-treatment follow-up 
to detect signs of any surgical complications such as he-
matoma, lymphocyst or relapses. Urethral mobility was 
assessed by placing a swab through urethral meatus into 
the urethra under sterile conditions and measuring the 
angle between the swab and the horizontal plane during 
resting and straining. If the difference between the angles 
was more than 30°, urethral mobility was considered posi-
tive [8, 9]. All patients were scanned with urinalysis before 
urodynamic assessment. Urinary cultures were procured 
when necessary. In the presence of any urinary tract infec-
tions, the urodynamic examination was postponed until the 
infection was cured.
Urodynamic assessment was performed with a “basic 
system urodynamics device” (Aymed Dyno, Urodynamics, 
Istanbul, Turkey). At the lithotomy position, a sterile 7F 3-lu-
men cystometry catheter was placed into the urethra and 
a rectal catheter with a 5 cc balloon into the rectum to 
measure the abdominal pressure concurrently. The device 
was calibrated before each operation. The bladder was filled 
with physiological saline at room temperature at thespeed 
of 50 mL/min. During filling cystometry, bladder capacity 
and compliance, vesical pressures, and abdominal pressures 
were measured. Detrusor pressure was calculated automati-
cally with the aid of a computer by subtracting the abdomi-
nal pressure from the vesical pressure (Pdet = Pves – Pabd). 
At the time of bladder filling, the patients were questioned 
about their first urge to urinate, normal urge to urinate, 
and severe urge to urinate, and their vesical and detrusor 
pressures were recorded during that time. 
The point which the patient declared a severe urge 
to urinate and could no longer delay urination was con-
sidered as “maximum cystometric bladder capacity”. The 
upwards fluctuations in detrusor pressure due to spontane-
ous or provocative maneuvers such as coughing or strain-
ing were termed as “involuntary detrusor contractions”. 
Whether or not the involuntary contractions resulted in 
incontinence, they were considered as an urodynamic 
indicator of an overactive detrusor. The pattern of detrusor 
contractions was noted as a single wave during bladder 
emptying. The patient was asked to cough at every 100 mL 
during bladder filling. Incontinence while coughing or 
thereafter was recorded. The increased abdominal pressure 
which leads to incontinence was termed as “abdominal leak 
point”. “Urodynamic stress incontinence” was described 
as involuntary incontinence when abdominal pressure 
increased without any detrusor contraction and “detrusor 
instability” as incontinence occurring due to involuntary 
detrusor contractions. 
Analyses were carried out using the SPSS 20.0 program 
(SPSS, Inc., Chicago, IL). Results were expressed as percent-
age and/or mean ± standard deviation (SD). ANOVA and 
Kruskal-Wallis tests were used to measure differences of 
variables among the groups. Student’s t-test was used for 
analyzing the differences of values before and after treat-
ment within the groups. The tests were performed using 
the 95% confidence interval and the statistical significance 
was set at p < 0.05. 
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RESULTS
There were no statistically significant differences be-
tween the three groups in terms of demographic, repro-
ductive, and comorbidity-related characteristics except for 
age, the number of menopausal patients, and smoking rate. 
Mean age, number of menopausal patients, and smoking 
rate were significantly higher in Group 2 (Table 1). Addition-
ally, radiation techniques and doses were shown in Table 2.
Pretreatment incontinence rates were similar in each 
group. However, a significant decrease in incontinence rate 
after treatment was only observed in Group 2 (p < 0.05). 
Similarly, pretreatment positive urethral mobility rate was 
significantly higher in Group 2 (p < 0.05) (Table 3).
Cystometry results of the groups were shown in Table 4. 
There was a significant decrease in the first urge to urinate 
volumes before and after treatment only in Group 2. On the 
other hand, the decrease in normal urge to urinate volumes 
before and after treatment was significant in both, Groups 
2 and 3 (p < 0.05). For the severe urge to urinate volumes 
before and after treatment, significant decreases were ob-
served in all of the investigated groups. 
A significant decrease was found in post-treatment 
maximum vesical pressure in Groups 1 and 3 (p = 0.012 and 
p = 0.008). In addition, there was a significant decrease in 
the maximum detrussor pressure before and after treatment 
only in Group 1 (p = 0.009). On the other hand, significant 
Table 1. Characteristics of the study groups
Group 1 Group 2 Group 3
Mean ± SD Mean ± SD Mean ± SD
n % n % n %
Age (year) 46.6 ± 8.6 59.5 ± 5.2 46.4 ±10.2
Max birthweight [g] 3250 ± 1169 3657 ± 247 3144 ± 1204
Gravidity
0 1 10% 0 0% 0 0%
≤ 2 4 40% 11 30.6% 4 44.4%
≥ 3 5 50% 25 69.4% 5 55.6%
Parity
0 1 10% 0 0% 1 11.1%
≤ 2 4 40% 18 50% 5 55.6%
≥ 3 5 50% 18 50% 3 33.3%
Menopause status 3 30% 36 100% 4 44.4%
Duration of menopause (year) 8,7 ± 1.5 10.8 ± 5.6 6.0 ± 4.2
Pelvic surgery 1 10% 0 0% 0 0%
Diabetes mellitus 1 10% 4 11.1% 2 22.2%
Hypertension 1 10% 9 25% 2 22.2%
Chronic lung disease 0 0% 0 0% 0 0%
Cigarette smoking 4 40% 2 5.6% 3 33.3%
SD — standard deviation
Table 2. Radiotherapy techniques and doses
Group 1 Group 2 Group 3
Mean ± SD Mean ± SD Mean ± SD
n % n % n %
RT techniques
BRT 0 0% 5 13.9% 0 0%
BRT 0 0% 13 36.1% 0 0%
BRT + ERT 10 100% 18 50.0% 9 100%
ERT dose [cGy] 4500 4570 ± 184 4940 ± 611
BRT dose [cGy] 1680 ± 278 1609 ± 464 2153 ± 594
Total dose [cGy] 6180 ± 278 4963 ± 1357 7093 ± 985
SD — standard deviation, BRT — brachytherapy, ERT — external radiotherapy
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Table 3. Pre and post-treatment incontinence occurence and results of Q-type test
Group 1 Group 2 Group 3
n % n % n %
Incontinence (PreT) 4 40% 10 27.8% 0 0%
Incontinence (PostT) 7 70% 14 38.9% 0 0%
Change in incontinance (PreT and PostT) p value 0.083 0.046 1.000
UM (PreT)
positive 0 0% 12 33.3% 0 0%
negative 10 100% 24 66.7% 9 100%
UM (PostT)
positive 0 0% 8 22.2% 0 0%
negative 10 100% 28 77.8% 9 100%
Change in UM (PreT and PostT) p value 1.000 0.157 1.000
UM — urethral mobility, PreT — pre-treatment, PostT — post-treatment
Table 4. Cystometry results of the study group
Group 1 Group 2 Group 3
FUUV [ml] (PreT) 335.9 ± 85.2 195 ± 80.1 202.9 ± 55.3
FUUV [ml] (PostT) 258.1 ± 133.0 186.9 ± 89.1 220.9 ± 39.0
Change in FUUV (PreT and PostT) p value 0.114 0.649 0.593
NUUV [ml] (PreT) 460.8 ± 109.3 351.2 ± 119.0 326.7 ± 87.8
NUUV [ml] (PostT) 387.3 ± 116.1 301.8 ± 101.7 280.6 ± 45.1
Change in NUUV (PreT and PostT) p value 0.093 0.037 0.440
SUUV [ml] (PreT) 570.5 ± 96.0 485.3 ± 145.3 466.2 ± 79.5
SUUV [ml] (PostT) 494.6 ± 144.0 393.8 ± 122.8 366.6 ± 85.7
Change in SUUV (PreT and PostT) p value 0.114 0.000 0.138
Data are presented as mean ± SD. FUUV — first urge tu urinate volume, PreT — pre-treatment, NUUV — normal urge to urinate volume, PostT — post-treatment,  
SUUV — severe urge to urinate volume
Table 5. Changes in bladder capacity, amount of residual urine, maximal vesical pressure and detrusor pressure
Group 1 Group 2 Group 3
Capacity [ml] (PreT) 662.2 ± 82.7 600.2 ± 124.8 593.0 ± 69.1
Capacity [ml] (PostT) 593.0 ± 68.9 490.0 ± 92.6 510.0 ± 103.3
Change in capacity (PreT and PostT) p value 0.005 0.000 0.05 
Residual urine [ml] (PreT) 5.1 ± 1.2 4.0 ± 1.3 4.4 ± 0.5
Residual urine [ml] (PostT) 4.8 ± 0.8 4.1 ± 1.0 4.4 ± 0.5
Change in residual urine (PreT and PostT) p value 0.180 0.914 0.257
MVP [cm/H2O] (PreT) 136.0 ± 24.4 129.3 ± 40.1 132.2 ± 50.1
MVP [cm/H2O] (PostT) 100.2 ± 32.6 130.2 ± 56.9 89.4 ± 30.8
Change in MVP (PreT and PostT) p value 0.012 0.793 0.008
MDP [cm/H2O] (PreT) 89.9 ± 31.4 69.4 ± 23.8 66.8 ± 43.8
MDP [cm/H2O] (PostT) 58.7 ± 23.9 77.7 ± 41.6 61.7 ± 41.7
Change in MDP (PreT and PostT) p value 0.009 0.338 0.515
Data are presented as mean ± SD. PreT — pre-treatment, MVP — maximmal vesical pressure, PostT — post-treatment, MDP — maximal detrusor pressure
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decreases were observed in the capacity after treatment 
in Groups 1 and 2 (p = 0.005 and p < 0.001, respectively). 
However, no significant differences in residual urine volumes 
before and after treatment were observed in any of the three 
groups (Table 5).
DISCUSSION
UI and urinary system disorders impair patient QoL and 
may lead to serious psychological, social, and sexual prob-
lems in women. Surgery and RT in gynecologic cancers are 
among the factors affecting the prevalence of UI [10]. Ad-
ditionally, advanced age and comorbidities, which are com-
mon in these patients, may also adversely affect continence. 
In our study, mean patient age was 46 ± 8.6, 59.5 ± 5.2, 
and 46.4 ± 10.2 years for Groups 1, 2 and 3, respectively. 
Numerous authors have emphasized age as the main factor 
promoting higher both, “urge” and “stress” incontinence. 
Also, hysterectomies performed in old age intensify their 
effects on the bladder function [10–12].
Short-term effects of hysterectomy and its influence on 
the lower urinary system functioning have been reported 
in retrospective studies [11, 13–16]. Frequency and urgency 
have been determined as the most common symptoms. It 
has also been reported that these symptoms usually disap-
pear approximately in three to six months [17]. Prospec-
tive studies on the short-term effects of hysterectomy 
confirmed lack of any detrimental effect of hysterectomy 
on bladder function [12, 18–20]. In a study by El-Youkhy 
et al., an urodynamic assessment of hysterectomized pa-
tients six months after surgery revealed no detrimental 
effects and resolution of urinary dysfunction symptoms 
was observed [20]. As far as studies on long-term effects of 
hysterectomy are concerned, to the best of our knowledge, 
a three-year observational study by Gustafsson et al., has 
been the only long-term prospective study in the literature 
[21]. However, no urodynamic assessment was performed 
in that study as only patient symptoms were investigated 
and no significant differences were found for the frequency 
of urge incontinence, stress incontinence, or voiding pat-
terns [21]. As for the available literature, only a few studies 
address the factors affecting incontinence, in terms of the 
number of patients, length and methods of monitoring, 
etc. In order to have a final result on individual effects of 
simple hysterectomy plus adjuvant RT, larger prospective 
and randomized studies with long-term monitoring should 
be designed. 
Also, we found no statistically significant differences in 
post-treatment frequency of incontinence and urethral mo-
bility results in RT after simple hysterectomy group. Similarly, 
we also found no significant differences in the urodynamic 
parameters six months after treatment. Based on these 
results and the available literature, simple hysterectomy fol-
lowed by adjuvant RT does not seem to cause lower urinary 
system dysfunction. 
Lower urinary system dysfunction is a well-known and 
frequent (reaching 80% in some series) complication of 
radical hysterectomy. Since the rate of developing a fistula 
has decreased below 1%, UI has become the most common 
surgery-related morbidity among RH patients. If autonomic 
nerve injury occurs during RH, urinary dysfunction, sexual 
dysfunction, and colorectal motility ailments may emerge 
according to the degree of the injury. The most common 
disorders include loss of sensation, hypertonic bladder, or 
hypo/a-contractile bladder, urgency and stress incontinence 
[22]. Axelsen et al., investigated 396 patients who filled out 
a questionnaire regarding urinary symptoms after RH. Over 
one-third developed UI and urine retention, however 78% 
of them did not consider these symptoms to constitute 
a problem [23]. Villena-Heinsen et al., performed a pre- 
and postoperative urodynamic assessment of 33 patients 
who underwent RH. While they observed no changes in 
urethral resistance, functional length, or urethral pres-
sure, they found the maximal bladder capacity to decrease 
from 615 mL to 503 mL in these patients. They also found 
a temporary decrease in maximal urinary flow and detrusor 
pressure and a delay in the first urge to urinate [24]. These 
authors pointed that incontinence was a common occur-
rence after RH. The condition regressed spontaneously in 
a considerable number of patients, however a urodynamic 
investigation had to be performed in cases of incontinence 
which persisted for over a year. In our study, we performed 
urodynamic tests six months after RT following RH and 
found a statistically significant, but clinically nonsignificant, 
decrease in bladder capacity (from 662 mL to 593 mL). Since 
normal bladder capacity is between 350–400 mL in healthy 
patients, this decrease may be of little significance in normal 
life. Additionally, we also found a statistically significant 
decrease in the maximal vesical and detrusor pressures. Al-
though there was a decrease in the first urge to urinate, 
normal urge to urinate, and severe urge to urinate volumes 
in urodynamic terms, the decrease was statistically insig-
nificant. Postoperatively, 70% of the patients complained 
of stress incontinence, while only 40% of them reported 
this complaint preoperatively. Also, there was an increase 
in the rates of frequent urination and urgency incontinence 
postoperatively. Considering that our findings, which are 
consistent with the literature, are early-stage results, we 
can expect that there will be a subsequent regress in urinary 
dysfunction symptoms over a long-term period of time.
Farquharson et al., studied early-stage effects of RT 
on bladder and urethral functions. They compared 30 pa-
tients who underwent only RH due to their cervical cancer, 
30 patients who received only RT, and 30 patients treated 
with RH and adjuvant RT with respect to urodynamics and 
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symptoms. Voiding disorders and loss of urinary sensation 
were more often observed in the RH group and the RH plus 
adjuvant RT group. While 50% of the RH patients developed 
a strained urination pattern, this problem developed in 
10% of the patients from the RT group. The only difference 
between the RH group and the RH plus adjuvant RT group 
was about bladder compliance but the difference was insig-
nificant as well. Six months after treatment the incontinence 
rates were 23% in the RT group, 26% in the RH group, and 
63% in the RH plus adjuvant RT group. The emergence of 
lower urinary system symptoms after RT was particularly 
linked to a decrease in compliance [25]. In another study 
by Lin et al., where primary RT and RT following RH were 
compared, strained urination and low compliance were 
found in both groups, but a significant decrease in bladder 
capacity was found in the RT following RH group [26]. In our 
study, we compared the six-month data of RH plus adjuvant 
RT and primary RT patients. We found a greater decrease in 
the first urge to urinate, normal urge to urinate, and severe 
urge to urinate volumes in the RH plus adjuvant RT group, 
while the decrease in bladder capacity was greater in the 
primary RT group. Also, a decrease in maximal vesical pres-
sure and maximal detrusor pressure was greater in the RH 
plus adjuvant RT group. 
We claimed that pelvic RT might caused demyelination 
on pelvic nerves and fibrosis on the bladder wall. Behr et al., 
reported that when the radiofibrosis associated with urge 
incontinence occurred, decreased bladder capacity and 
increased bladder tonus could be found concurrently, but 
these symptoms were partially recoverable [27]. Parkin et al., 
urodynamically assessed primary RT patients due to cervical 
cancer and found a significant decrease in the first urge to 
urinate volumes and maximal cystometric capacities. They 
claimed that urgency, frequency, and urge incontinence 
caused by decreased bladder capacity alone could not be 
the only reason, and that detrusor instability also played 
a role in the occurrence of these symptoms [4]. Barraclough 
et al., in their large-scale prospective study with 226 patients, 
observed that urgency, frequency and UI occurred in the 
early period following RT in these patients, but a significant 
increase occurred in the third year, especially in urgency and 
frequency [28]. In our study, the pre-RT urodynamic assess-
ments of the primary RT patients was normal and a decrease 
was observed in the normal urge to urinate, severe urge to 
urinate, and maximal bladder capacity at 6-month follow-up. 
While there was a decrease in the maximal vesical pressure, 
there was no significant difference in maximal detrusor 
pressure. We also observed that the urgency-frequency 
symptoms were clinically more obvious in the primary RT 
group after six months. There were no complaints of stress 
incontinence in any of the adjuvant RT after hysterectomy 
patients, either pre-treatment or six months after treat-
ment. Average bladder capacity was markedly lower after 
six months in the primary RT group than in the adjuvant RT 
following hysterectomy group. We related this result due 
to dose difference of approximately 1000 cGy on average 
between the adjuvant and primary RT protocols (6180 cGy 
vs. 7093 cGy, respectively). 
Our study is not without limitations. First of all, the sam-
ple size was relatively small and we did not evaluate the ef-
fect of radical surgery alone, which might have helped us to 
assess the impact of radiation separately on urinary system 
functions. However, the findings suggest that adjuvant RT 
following RH may result in the lower urinary system dysfunc-
tion, although this might confound the results for patients 
in the radiation cohort who did not receive uniform radia-
tion treatment. Although our study consisted of combined 
analysis of objective and subjective data obtained from 
a limited number of patients, we believe that it will serve 
as a guide for other prospective studies with larger sample 
size and longer monitoring periods. As cancer treatments 
aim at prolonging the survival without impairing patient 
QoL, further studies will be necessary to determine how to 
prevent urinary system dysfunction or decrease the detri-
mental effects during treatment.
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